TY  - RPRT
TI  - FDA approved PDE4 inhibitors reduce the dominant toxicity of ALS/FTD associated CHCHD10S59L
AU  - Maitra, S.
AU  - Baek, M.
AU  - Choe, Y.-J.
AU  - Kim, N. C.
PY  - 2024
DO  - 10.1101/2024.06.04.597429
UR  - https://www.biorxiv.org/content/10.1101/2024.06.04.597429v1
ID  - 10.1101/2024.06.04.597429
ER  -